Looking for undervalued stocks with explosive growth potential? These two forgotten market darlings of the pandemic lockdowns are still thriving in 2025.
Although the S&P 500 is down 1.4% over the past six months, BrightView’s stock price has fallen further to $13.27, losing shareholders 15.7% of their capital. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
What a brutal six months it’s been for AAON. The stock has dropped 25.6% and now trades at $80.24, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Over the last six months, EMCOR shares have sunk to $379, producing a disappointing 12% loss - worse than the S&P 500’s 1.4% drop. This might have investors contemplating their next move.
Over the past six months, Lam Research’s shares (currently trading at $74.44) have posted a disappointing 8.8% loss while the S&P 500 was down 1.4%. This may have investors wondering how to approach the situation.
Although the S&P 500 is down 1.4% over the past six months, Gibraltar’s stock price has fallen further to $62.15, losing shareholders 11.1% of their capital. This may have investors wondering how to approach the situation.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at BrightSpring Health Services (NASDAQ:BTSG) and its peers.
Morgan Stanley expects the core monthly PCE rate to be 0.35%, rounding off to 0.4%, nudged higher by strong goods inflation and an acceleration in core services prices, excluding housing.
The new tab introduced in the U.S. and Canada on Thursday will show content from a user’s Facebook friends, such as stories, reels, posts, birthdays and friend requests.
Stronger-than-expected Tokyo consumer price inflation, and signs of broadening pressures, support our long-held view that the Bank of Japan will hike in May.
